Vestmark Advisory Solutions’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.9M | Sell |
126,735
-775
| -0.6% | -$167K | 0.3% | 75 |
|
|
2026
Q1 | $27.7M | Buy |
127,510
+30,233
| +31% | +$6.71M | 0.31% | 66 |
|
|
2025
Q4 | $22.2M | Buy |
97,277
+53,045
| +120% | +$12.1M | 0.3% | 63 |
|
|
2025
Q3 | $10.2M | Buy |
44,232
+1,175
| +3% | +$239K | 0.2% | 110 |
|
|
2025
Q2 | $7.99M | Buy |
43,057
+4,169
| +11% | +$775K | 0.12% | 139 |
|
|
2025
Q1 | $8.15M | Buy |
38,888
+17,788
| +84% | +$3.46M | 0.21% | 126 |
|
|
2024
Q4 | $3.75M | Buy |
21,100
+2,505
| +13% | +$461K | 0.13% | 164 |
|
|
2024
Q3 | $3.67M | Sell |
18,595
-6,116
| -25% | -$1.14M | 0.14% | 154 |
|
|
2024
Q2 | $4.24M | Buy |
24,711
+6,129
| +33% | +$1.02M | 0.18% | 129 |
|
|
2024
Q1 | $3.38M | Sell |
18,582
-864
| -4% | -$149K | 0.15% | 172 |
|
|
2023
Q4 | $3.01M | Sell |
19,446
-1,459
| -7% | -$213K | 0.15% | 171 |
|
|
2023
Q3 | $3.12M | Sell |
20,905
-59,248
| -74% | -$8.7M | 0.23% | 103 |
|
|
2023
Q2 | $10.8M | Buy |
80,153
+1,980
| +3% | +$290K | 0.41% | 50 |
|
|
2023
Q1 | $12.5M | Sell |
78,173
-738
| -0.9% | -$113K | 0.54% | 30 |
|
|
2022
Q4 | $12.8M | Buy |
78,911
+396
| +0.5% | +$60.7K | 0.62% | 23 |
|
|
2022
Q3 | $10.5M | Buy |
78,515
+7,631
| +11% | +$1.1M | 0.59% | 24 |
|
|
2022
Q2 | $10.9M | Buy |
70,884
+11,724
| +20% | +$1.79M | 0.62% | 23 |
|
|
2022
Q1 | $9.59M | Buy |
59,160
+3,413
| +6% | +$496K | 0.54% | 29 |
|
|
2021
Q4 | $7.55M | Buy |
55,747
+2,206
| +4% | +$261K | 0.43% | 41 |
|
|
2021
Q3 | $5.78M | Buy |
53,541
+10,606
| +25% | +$1.21M | 0.39% | 45 |
|
|
2021
Q2 | $4.84M | Buy |
42,935
+1,260
| +3% | +$142K | 0.34% | 59 |
|
|
2021
Q1 | $4.51M | Buy |
41,675
+2,154
| +5% | +$230K | 0.4% | 50 |
|
|
2020
Q4 | $4.24M | Buy |
39,521
+228
| +0.6% | +$21.9K | 0.48% | 43 |
|
|
2020
Q3 | $3.44M | Buy |
39,293
+2,615
| +7% | +$246K | 0.46% | 45 |
|
|
2020
Q2 | $3.6M | Buy |
36,678
+17,974
| +96% | +$1.58M | 0.56% | 36 |
|
|
2020
Q1 | $1.43M | Buy |
18,704
+1,489
| +9% | +$127K | 0.28% | 102 |
|
|
2019
Q4 | $1.52M | Buy |
17,215
+292
| +2% | +$24.2K | 0.31% | 115 |
|
|
2019
Q3 | $1.28M | Buy |
16,923
+4,382
| +35% | +$300K | 0.21% | 150 |
|
|
2019
Q2 | $912K | Buy |
12,541
+248
| +2% | +$19.5K | 0.16% | 189 |
|
|
2019
Q1 | $991K | Buy |
+12,293
| New | +$1.01M | 0.18% | 171 |
|
Other funds holding ABBV
Vestmark Advisory Solutions's ABBV Position: Q2 2026 in Review
Vestmark Advisory Solutions reduced its AbbVie (ABBV) stake by 0.61% in Q2 2026, selling an estimated $167K and leaving 126,735 shares worth $31.9M. The position accounts for 0.3% of the portfolio, ranked #75.
Vestmark Advisory Solutions first reported a position in ABBV in Q1 2019 and has held it in 30 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Vestmark Advisory Solutions held 126,735 shares of AbbVie worth $31.9M as of Q2 2026.
- Vestmark Advisory Solutions sold 775 AbbVie shares in Q2 2026, an estimated $167K.
- AbbVie made up 0.3% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #75 holding.
- Vestmark Advisory Solutions first reported a position in AbbVie in Q1 2019 and has held it in 30 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.